Leader of the parallel import market, Medifarm was founded in 1998 withthe aim of distributing drugs and para-pharmaceuticals in Europe. Over the years, the company has undergone a transformation becoming part of a European multinational group with offices in France, Great Britain, Spain, Germany and the Netherlands; the structure has also expanded thanks to the contribution of professionals in the field.
The free movement of pharmaceutical goods in the European community allows to obtain more competitive prices, crucial for encouraging therapeutic innovation and ensuring the well-being of patients. At the same time, it is necessary to reconcile these priorities with the aim of favouring the control of public health expenditure in the member states of the European Union.